Ifosfamide-Induced Encephalopathy Managed Successfully with Methylene Blue in a Child with Wilms Tumor: A Case Report and Review of the Literature
| Author | Atbin Latifi | en |
| Author | Sina Yousefian | en |
| Author | Sina Azimi | en |
| Orcid | Atbin Latifi [0000-0003-2115-9910] | en |
| Orcid | Sina Yousefian [0009-0001-5046-5047] | en |
| Orcid | Sina Azimi [0009-0001-6863-2122] | en |
| Issued Date | 2024-11-30 | en |
| Abstract | Introduction: Ifosfamide is a crucial element in various chemotherapy protocols for the treatment of diverse solid tumors in both children and adults. Despite its efficacy, ifosfamide is associated with a rare yet severe adverse effect known as ifosfamide-induced encephalopathy (IIE), with a spectrum of signs and symptoms spanning from mild lethargy to coma or death. While approximately 13% of pediatric patients undergoing ifosfamide treatment experience IIE, consensus regarding its management remains controversial. Case Presentation: We present the case of a 4-year-old girl with stage 4 Wilms tumor and lung metastases who underwent radical nephrectomy followed by UH-1 chemotherapy. Imaging post-chemotherapy initially showed tumor clearance but later revealed relapse and lung metastasis. Following the initiation of the adjusted ICE protocol (ifosfamide, etoposide), the patient developed IIE, which was successfully treated with methylene blue. Conclusions: We strongly advise pediatric oncologists and hematologists to proactively consider the potential occurrence of IIE. Before starting ifosfamide therapy, patients should be assessed for possible risk factors associated with IIE. Considering methylene blue as a prophylactic measure is recommended for patients with significant risk factors. In cases where IIE manifests, using Methylene Blue to alleviate and reverse its signs and symptoms should be considered. Moreover, we highly encourage further research endeavors to validate methylene blue's effectiveness and determine its optimal dosage range, especially concerning pediatric patients. | en |
| DOI | https://doi.org/10.5812/jcp-153676 | en |
| Keyword | Ifosfamide | en |
| Keyword | Encephalopathy | en |
| Keyword | Methylene Blue | en |
| Keyword | Neurotoxicity | en |
| Keyword | Child | en |
| Publisher | Brieflands | en |
| Title | Ifosfamide-Induced Encephalopathy Managed Successfully with Methylene Blue in a Child with Wilms Tumor: A Case Report and Review of the Literature | en |
| Type | Case Report | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- jcp-15-4-153676-publish-pdf.pdf
- Size:
- 922.17 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF